Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

v3.23.1
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 3,282 $ 7,253
Restricted cash 34 34
Accounts receivable, net of allowance of $450 and $647 as of March 31, 2023 and December 31, 2022, respectively 24,753 46,565
Inventory 15,802 18,556
Prepaid expenses and other current assets 17,907 17,289
Assets held for sale – current 12,592
Total current assets 74,370 89,697
Property, plant and equipment, net 5,972 7,351
Goodwill 13,641
Intangible assets, net 5,302
Right-of-use assets, net 4,230 5,697
Other non-current assets 20,160 3,407
Assets held for sale – non-current 20,791
Total assets 125,523 125,095
Current liabilities:    
Accounts payable 16,957 26,173
Accrued expenses and other current liabilities 30,401 32,243
Deferred revenue 1,957 2,892
Senior term loan, current portion 40,993 40,529
Subordinated debt 11,256 11,119
Subordinated term loan – related party 42,449 41,528
Convertible debt 45,492 43,928
Current portion of long-term debt 263 259
Liabilities held for sale – current 11,963
Total current liabilities 201,731 198,671
Other long-term liabilities 6,408 7,223
Liabilities held for sale – non-current 17,294
Total liabilities 225,433 205,894
Stockholders’ deficit:    
Common stock, $0.0001 par value; 250,000,000 shares authorized; 74,582,992 and 74,283,026 shares issued and outstanding as of March 31, 2023 and December 31, 2022 7 7
Additional paid-in capital 772,205 770,427
Accumulated deficit (872,122) (851,233)
Total stockholders’ deficit (99,910) (80,799)
Total liabilities and stockholders’ deficit $ 125,523 $ 125,095